Captor Therapeutics Spolka Akcyjna (WSE:CTX)

WSE:CTX Statistics

Total Valuation

WSE:CTX has a market cap or net worth of PLN 267.04 million. The enterprise value is 219.75 million.

Market Cap	267.04M
Enterprise Value	219.75M

Important Dates

The next estimated earnings date is Monday, November 24, 2025.

Earnings Date	Nov 24, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:CTX has 5.53 million shares outstanding. The number of shares has increased by 4.23% in one year.

Current Share Class	5.53M
Shares Outstanding	5.53M
Shares Change (YoY)	+4.23%
Shares Change (QoQ)	+0.42%
Owned by Insiders (%)	30.80%
Owned by Institutions (%)	23.03%
Float	3.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.06
PB Ratio	5.96
P/TBV Ratio	6.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.57
EV / Sales	19.80
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-89.55

Financial Position

The company has a current ratio of 5.29, with a Debt / Equity ratio of 0.03.

Current Ratio	5.29
Quick Ratio	5.29
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.59
Interest Coverage	-113.30

Financial Efficiency

Return on equity (ROE) is -82.69% and return on invested capital (ROIC) is -52.79%.

Return on Equity (ROE)	-82.69%
Return on Assets (ROA)	-41.09%
Return on Invested Capital (ROIC)	-52.79%
Return on Capital Employed (ROCE)	-95.83%
Revenue Per Employee	121,978
Profits Per Employee	-433,802
Employee Count	91
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.29% in the last 52 weeks. The beta is 0.71, so WSE:CTX's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-30.29%
50-Day Moving Average	40.07
200-Day Moving Average	39.99
Relative Strength Index (RSI)	71.60
Average Volume (20 Days)	12,902

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:CTX had revenue of PLN 11.10 million and -39.48 million in losses. Loss per share was -7.77.

Revenue	11.10M
Gross Profit	5.33M
Operating Income	-43.62M
Pretax Income	-39.48M
Net Income	-39.48M
EBITDA	-38.49M
EBIT	-43.62M
Loss Per Share	-7.77

Balance Sheet

The company has 48.74 million in cash and 1.45 million in debt, giving a net cash position of 47.29 million or 8.55 per share.

Cash & Cash Equivalents	48.74M
Total Debt	1.45M
Net Cash	47.29M
Net Cash Per Share	8.55
Equity (Book Value)	44.80M
Book Value Per Share	8.10
Working Capital	40.87M

Cash Flow

In the last 12 months, operating cash flow was -1.95 million and capital expenditures -506,000, giving a free cash flow of -2.45 million.

Operating Cash Flow	-1.95M
Capital Expenditures	-506,000
Free Cash Flow	-2.45M
FCF Per Share	-0.44

Margins

Gross Margin	48.00%
Operating Margin	-392.98%
Pretax Margin	-355.64%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WSE:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.23%
Shareholder Yield	-4.23%
Earnings Yield	-14.78%
FCF Yield	-0.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:CTX has an Altman Z-Score of 8 and a Piotroski F-Score of 2.

Altman Z-Score	8
Piotroski F-Score	2